From the bard

For 11 years, Richard Steinman, an MD, PhD, has been penning sonnets in honor of newly minted grads of the Medical Scientist Training Program. Here’s a taste, in the form of his second stanza recognizing Class of 2023 MD, PhD graduates Oyin Dosunmu-Ogunbi and Joshua Tashman.

The sick in sickle cell awaits a cure.
The villain—superoxide—will concede
to SOD2 (“hero”) to ensure
that mitos work and sickle sick recedes
In nearly half, of African descent,
a SOD2 SNP is kryptonite—
that’s Oyin’s skillful find. Next, she’ll augment
the team at Boston Peds with her insights

Josh Tashman—what a set of FRESH insights
he brought to transform how organs can grow.
He’ll spray a heart or kidney parts in bytes,
in 3D molds like loaves from tissue dough.
With Josh in Path at Brigham, this dynam-
ic duo bats a Fenway Park grand slam.

Read more from the Fall 2023 issue.